Primary Prevention of Colorectal Cancer

2009 Curado, 2007 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Giovannucci, 1994, Dietary factors and risk of colon cancer, Ann Med, 26, 443, 10.3109/07853899409148367 Burkitt, 1969, Related disease—related cause?, Lancet, 2, 1229, 10.1016/S0140-6736(69)90757-0 Kritchevsky, 1995, Epidemiology of fibre, resistant starch and colorectal cancer, Eur J Cancer Prev, 4, 345, 10.1097/00008469-199510000-00003 Levi, 2001, Dietary fibre and the risk of colorectal cancer, Eur J Cancer, 37, 2091, 10.1016/S0959-8049(01)00254-4 Trock, 1990, Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence, J Natl Cancer Inst, 82, 650, 10.1093/jnci/82.8.650 Howe, 1992, Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies, J Natl Cancer Inst, 84, 1887, 10.1093/jnci/84.24.1887 Willett, 1990, Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women, N Engl J Med, 323, 1664, 10.1056/NEJM199012133232404 Goldbohm, 1994, A prospective cohort study on the relation between meat consumption and the risk of colon cancer, Cancer Res, 54, 718 Bostick, 1994, Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States), Cancer Causes Control, 5, 38, 10.1007/BF01830725 Fuchs, 1999, Dietary fiber and the risk of colorectal cancer and adenoma in women, N Engl J Med, 340, 169, 10.1056/NEJM199901213400301 Michels, 2000, Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers, J Natl Cancer Inst, 92, 1740, 10.1093/jnci/92.21.1740 Pietinen, 1999, Diet and risk of colorectal cancer in a cohort of Finnish men, Cancer Causes Control, 10, 387, 10.1023/A:1008962219408 Park, 2005, Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies, JAMA, 294, 2849, 10.1001/jama.294.22.2849 Koushik, 2007, Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies, J Natl Cancer Inst, 99, 1471, 10.1093/jnci/djm155 Bingham, 2003, Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study, Lancet, 361, 1496, 10.1016/S0140-6736(03)13174-1 van Duijnhoven, 2009, Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition, Am J Clin Nutr, 89, 1441, 10.3945/ajcn.2008.27120 Schatzkin, 2000, Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas, N Engl J Med, 342, 1149, 10.1056/NEJM200004203421601 Alberts, 2000, Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas, N Engl J Med, 342, 1156, 10.1056/NEJM200004203421602 Bonithon-Kopp, 2000, Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial, Lancet, 356, 1300, 10.1016/S0140-6736(00)02813-0 Le Leu, 2007, Suppression of azoxymethane-induced colon cancer development in rats by dietary resistant starch, Cancer Biol Ther, 6, 1621, 10.4161/cbt.6.10.4764 Le Leu, 2007, Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats, Carcinogenesis, 28, 240, 10.1093/carcin/bgl245 Dronamraju, 2009, Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch: a randomised controlled trial, Gut, 58, 413, 10.1136/gut.2008.162933 Young, 2004, Resistant starch and colorectal neoplasia, J AOAC Int, 87, 775, 10.1093/jaoac/87.3.775 Burn, 2008, Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome, N Engl J Med, 359, 2567, 10.1056/NEJMoa0801297 Benito, 1993, Diet and colorectal adenomas: a case-control study in Majorca, Int J Cancer, 55, 213, 10.1002/ijc.2910550208 Benito, 1990, A population-based case-control study of colorectal cancer in Majorca, Int J Cancer, 45, 69, 10.1002/ijc.2910450114 Chao, 2005, Meat consumption and risk of colorectal cancer, Jama, 293, 172, 10.1001/jama.293.2.172 Cross, 2007, A prospective study of red and processed meat intake in relation to cancer risk, PLoS Med, 4, e325, 10.1371/journal.pmed.0040325 English, 2004, Red meat, chicken, and fish consumption and risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 13, 1509, 10.1158/1055-9965.1509.13.9 Gaard, 1996, Dietary factors and risk of colon cancer: a prospective study of 50,535 young Norwegian men and women, Eur J Cancer Prev, 5, 445 Gerhardsson de Verdier, 1991, Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm, Int J Cancer, 49, 520, 10.1002/ijc.2910490408 Giovannucci, 1992, Relationship of diet to risk of colorectal adenoma in men, J Natl Cancer Inst, 84, 91, 10.1093/jnci/84.2.91 Larsson, 2005, Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort, Int J Cancer, 113, 829, 10.1002/ijc.20658 Lee, 1989, Colorectal cancer and diet in an Asian population—a case-control study among Singapore Chinese, Int J Cancer, 43, 1007, 10.1002/ijc.2910430609 Martinez, 2007, Meat intake, preparation methods, mutagens and colorectal adenoma recurrence, Carcinogenesis, 28, 2019, 10.1093/carcin/bgm179 Neugut, 1993, Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps, Ann Intern Med, 118, 91, 10.7326/0003-4819-118-2-199301150-00002 Norat, 2005, Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition, J Natl Cancer Inst, 97, 906, 10.1093/jnci/dji164 Shin, 2007, Meat and meat-mutagen intake, doneness preference and the risk of colorectal polyps: the Tennessee Colorectal Polyp Study, Int J Cancer, 121, 136, 10.1002/ijc.22664 Steinmetz, 1993, Food-group consumption and colon cancer in the Adelaide Case-Control Study. II. Meat, poultry, seafood, dairy foods and eggs, Int J Cancer, 53, 720, 10.1002/ijc.2910530503 Stemmermann, 1984, Dietary fat and the risk of colorectal cancer, Cancer Res, 44, 4633 Young, 1988, Case-control study of proximal and distal colon cancer and diet in Wisconsin, Int J Cancer, 42, 167, 10.1002/ijc.2910420205 Norat, 2002, Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies, Int J Cancer, 98, 241, 10.1002/ijc.10126 Robertson, 2005, Fat, fiber, meat and the risk of colorectal adenomas, Am J Gastroenterol, 100, 2789, 10.1111/j.1572-0241.2005.00336.x Sandhu, 2001, Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach, Cancer Epidemiol Biomarkers Prev, 10, 439 Bird, 1996, Plasma ferritin, iron intake, and the risk of colorectal polyps, Am J Epidemiol, 144, 34, 10.1093/oxfordjournals.aje.a008852 Nelson, 1994, Body iron stores and risk of colonic neoplasia, J Natl Cancer Inst, 86, 455, 10.1093/jnci/86.6.455 Shaheen, 2003, Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer, J Natl Cancer Inst, 95, 154, 10.1093/jnci/95.2.154 Wurzelmann, 1996, Iron intake and the risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 5, 503 Lee, 2004, Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study, J Natl Cancer Inst, 96, 403, 10.1093/jnci/djh047 Tseng, 2000, Serum ferritin concentration and recurrence of colorectal adenoma, Cancer Epidemiol Biomarkers Prev, 9, 625 Tseng, 1997, Dietary iron and recurrence of colorectal adenomas, Cancer Epidemiol Biomarkers Prev, 6, 1029 Chan, 2005, Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women, J Natl Cancer Inst, 97, 917, 10.1093/jnci/dji165 Probst-Hensch, 1997, Meat preparation and colorectal adenomas in a large sigmoidoscopy-based case-control study in California (United States), Cancer Causes Control, 8, 175, 10.1023/A:1018416128894 Sinha, 1999, Well-done, grilled red meat increases the risk of colorectal adenomas, Cancer Res, 59, 4320 Sugimura, 1985, Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process, Mutat Res, 150, 33, 10.1016/0027-5107(85)90098-3 Sugimura, 1997, Overview of carcinogenic heterocyclic amines, Mutat Res, 376, 211, 10.1016/S0027-5107(97)00045-6 Wakabayashi, 1992, Food-derived mutagens and carcinogens, Cancer Res, 52, 2092s Ferrucci, 2009, Dietary meat intake in relation to colorectal adenoma in asymptomatic women, Am J Gastroenterol, 104, 1231, 10.1038/ajg.2009.102 Gunter, 2005, Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control study, Carcinogenesis, 26, 637, 10.1093/carcin/bgh350 Ishibe, 2002, Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas, Pharmacogenetics, 12, 145, 10.1097/00008571-200203000-00008 Kampman, 1999, Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study, Cancer Epidemiol Biomarkers Prev, 8, 15 Le Marchand, 2002, Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii, Mutat Res, 506–507, 205, 10.1016/S0027-5107(02)00167-7 Nowell, 2002, Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk, Mutat Res, 506–507, 175, 10.1016/S0027-5107(02)00164-1 Sinha, 2001, Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas, Cancer Epidemiol Biomarkers Prev, 10, 559 Sinha, 2005, Dietary benzo[a]pyrene intake and risk of colorectal adenoma, Cancer Epidemiol Biomarkers Prev, 14, 2030, 10.1158/1055-9965.EPI-04-0854 Sinha, 2005, Meat, meat cooking methods and preservation, and risk for colorectal adenoma, Cancer Res, 65, 8034, 10.1158/0008-5472.CAN-04-3429 Wu, 2006, Meat mutagens and risk of distal colon adenoma in a cohort of U.S. men, Cancer Epidemiol Biomarkers Prev, 15, 1120, 10.1158/1055-9965.EPI-05-0782 Gunter, 2007, Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma, Carcinogenesis, 28, 1426, 10.1093/carcin/bgm022 Peters, 2003, Urinary mutagenicity and colorectal adenoma risk, Cancer Epidemiol Biomarkers Prev, 12, 1253 Butler, 2008, Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study, Mutat Res, 638, 162, 10.1016/j.mrfmmm.2007.10.002 Chen, 1998, A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer, Cancer Res, 58, 3307 Joshi, 2009, Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk, Carcinogenesis, 30, 472, 10.1093/carcin/bgn260 Lang, 1994, Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps, Cancer Epidemiol Biomarkers Prev, 3, 675 Le Marchand, 2001, Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk, Cancer Epidemiol Biomarkers Prev, 10, 1259 Probst-Hensch, 1995, Acetylation polymorphism and prevalence of colorectal adenomas, Cancer Res, 55, 2017 Roberts-Thomson, 1996, Diet, acetylator phenotype, and risk of colorectal neoplasia, Lancet, 347, 1372, 10.1016/S0140-6736(96)91012-0 Shin, 2008, Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk, Cancer Epidemiol Biomarkers Prev, 17, 320, 10.1158/1055-9965.EPI-07-0615 Chan, 2005, Prospective study of N-acetyltransferase-2 genotypes, meat intake, smoking and risk of colorectal cancer, Int J Cancer, 115, 648, 10.1002/ijc.20890 Chiu, 2003, Dietary factors and risk of colon cancer in Shanghai, China, Cancer Epidemiol Biomarkers Prev, 12, 201 Kato, 1997, Prospective study of diet and female colorectal cancer: the New York University Women's Health Study, Nutrition and Cancer, 28, 276, 10.1080/01635589709514588 Geelen, 2007, Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies, Am J Epidemiol, 166, 1116, 10.1093/aje/kwm197 Hall, 2007, Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 16, 314, 10.1158/1055-9965.EPI-06-0346 Hall, 2008, A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men, Cancer Epidemiol Biomarkers Prev, 17, 1136, 10.1158/1055-9965.EPI-07-2803 Larsson, 2004, Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms, Am J Clin Nutr, 79, 935, 10.1093/ajcn/79.6.935 Oh, 2005, Dietary marine n-3 fatty acids in relation to risk of distal colorectal adenoma in women, Cancer Epidemiol Biomarkers Prev, 14, 835, 10.1158/1055-9965.EPI-04-0545 Daniel, 2009, Dietary intake of omega-6 and omega-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women, Cancer Epidemiol Biomarkers Prev, 18, 516, 10.1158/1055-9965.EPI-08-0750 Lopez-Garcia, 2004, Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women, J Nutr, 134, 1806, 10.1093/jn/134.7.1806 Lim, 2008, Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids, Cancer Res, 68, 553, 10.1158/0008-5472.CAN-07-2295 Nowak, 2007, Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids, Carcinogenesis, 28, 1991, 10.1093/carcin/bgm166 Benito, 1991, Nutritional factors in colorectal cancer risk: a case-control study in Majorca, Int J Cancer, 49, 161, 10.1002/ijc.2910490202 Freudenheim, 1990, A case-control study of diet and rectal cancer in western New York, Am J Epidemiol, 131, 612, 10.1093/oxfordjournals.aje.a115545 Franceschi, 2001, Dietary glycemic load and colorectal cancer risk, Ann Oncol, 12, 173, 10.1023/A:1008304128577 Gnagnarella, 2008, Glycemic index, glycemic load, and cancer risk: a meta-analysis, Am J Clin Nutr, 87, 1793, 10.1093/ajcn/87.6.1793 Higginbotham, 2004, Dietary glycemic load and risk of colorectal cancer in the Women's Health Study, J Natl Cancer Inst, 96, 229, 10.1093/jnci/djh020 McCarl, 2006, Incidence of colorectal cancer in relation to glycemic index and load in a cohort of women, Cancer Epidemiol Biomarkers Prev, 15, 892, 10.1158/1055-9965.EPI-05-0700 Michaud, 2005, Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women, Cancer Epidemiol Biomarkers Prev, 14, 138, 10.1158/1055-9965.138.14.1 Flood, 2006, Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study, Am J Clin Nutr, 84, 1184, 10.1093/ajcn/84.5.1184 Howarth, 2008, The association of glycemic load and carbohydrate intake with colorectal cancer risk in the Multiethnic Cohort Study, Am J Clin Nutr, 88, 1074, 10.1093/ajcn/88.4.1074 Kabat, 2008, Dietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women's Health Initiative, Cancer Causes Control, 19, 1291, 10.1007/s10552-008-9200-3 Larsson, 2007, Dietary carbohydrate, glycemic index, and glycemic load in relation to risk of colorectal cancer in women, Am J Epidemiol, 165, 256, 10.1093/aje/kwk012 Mulholland, 2009, Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and meta-analysis, Am J Clin Nutr, 89, 568, 10.3945/ajcn.2008.26823 Oh, 2004, Glycemic index, glycemic load, and carbohydrate intake in relation to risk of distal colorectal adenoma in women, Cancer Epidemiol Biomarkers Prev, 13, 1192, 10.1158/1055-9965.1192.13.7 Strayer, 2007, Dietary carbohydrate, glycemic index, and glycemic load and the risk of colorectal cancer in the BCDDP cohort, Cancer Causes Control, 18, 853, 10.1007/s10552-007-9030-8 Weijenberg, 2008, Dietary glycemic load, glycemic index and colorectal cancer risk: results from the Netherlands Cohort Study, Int J Cancer, 122, 620, 10.1002/ijc.23110 Newmark, 1984, Colon cancer and dietary fat, phosphate, and calcium: a hypothesis, J Natl Cancer Inst, 72, 1323 van der Meer, 1985, Differential binding of glycine- and taurine-conjugated bile acids to insoluble calcium phosphate, Biochem J, 229, 265, 10.1042/bj2290265 Fedirko, 2009, Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial, Cancer Prev Res (Phila Pa), 2, 213, 10.1158/1940-6207.CAPR-08-0157 Fedirko, 2009, Effects of vitamin D and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial, Cancer Epidemiol Biomarkers Prev, 18, 2933, 10.1158/1055-9965.EPI-09-0239 Lipkin, 1985, Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer, N Engl J Med, 313, 1381, 10.1056/NEJM198511283132203 Martinez, 1998, Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence, Cancer Epidemiol Biomarkers Prev, 7, 163 Wu, 2002, Calcium intake and risk of colon cancer in women and men, J Natl Cancer Inst, 94, 437, 10.1093/jnci/94.6.437 Cho, 2004, Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies, J Natl Cancer Inst, 96, 1015, 10.1093/jnci/djh185 Baron, 1999, Calcium supplements for the prevention of colorectal adenomas, N Engl J Med, 340, 101, 10.1056/NEJM199901143400204 Wallace, 2004, Effect of calcium supplementation on the risk of large bowel polyps, J Natl Cancer Inst, 96, 921, 10.1093/jnci/djh165 Grau, 2007, Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial, J Natl Cancer Inst, 99, 129, 10.1093/jnci/djk016 Grau, 2003, Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial, J Natl Cancer Inst, 95, 1765, 10.1093/jnci/djg110 Garland, 1980, Do sunlight and vitamin D reduce the likelihood of colon cancer?, Int J Epidemiol, 9, 227, 10.1093/ije/9.3.227 Giovannucci, 2005, The epidemiology of vitamin D and cancer incidence and mortality: a review (United States), Cancer Causes Control, 16, 83, 10.1007/s10552-004-1661-4 Froicu, 2003, A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases, Mol Endocrinol, 17, 2386, 10.1210/me.2003-0281 Froicu, 2006, Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice, Immunology, 117, 310, 10.1111/j.1365-2567.2005.02290.x Cantorna, 2000, 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease, J Nutr, 130, 2648, 10.1093/jn/130.11.2648 Fichera, 2007, A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model, J Surg Res, 142, 239, 10.1016/j.jss.2007.02.038 Zhu, 2005, Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease, Eur J Immunol, 35, 217, 10.1002/eji.200425491 Dresner-Pollak, 2004, The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients, Genet Test, 8, 417, 10.1089/gte.2004.8.417 Gilman, 2006, Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis, Aliment Pharmacol Ther, 23, 1007, 10.1111/j.1365-2036.2006.02835.x Lim, 2005, Mechanisms of disease: vitamin D and inflammatory bowel disease, Nat Clin Pract Gastroenterol Hepatol, 2, 308, 10.1038/ncpgasthep0215 Peterlik, 2005, Vitamin D and calcium deficits predispose for multiple chronic diseases, Eur J Clin Invest, 35, 290, 10.1111/j.1365-2362.2005.01487.x Simmons, 2000, Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility, Gut, 47, 211, 10.1136/gut.47.2.211 Dietrich, 2005, Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation, Am J Clin Nutr, 82, 575, 10.1093/ajcn/82.3.575 Dietrich, 2004, Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population, Am J Clin Nutr, 80, 108 Timms, 2002, Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?, QJM, 95, 787, 10.1093/qjmed/95.12.787 Otani, 2007, Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study, Br J Cancer, 97, 446, 10.1038/sj.bjc.6603892 Braun, 1995, Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis, Am J Epidemiol, 142, 608, 10.1093/oxfordjournals.aje.a117682 Feskanich, 2004, Plasma vitamin D metabolites and risk of colorectal cancer in women, Cancer Epidemiol Biomarkers Prev, 13, 1502, 10.1158/1055-9965.1502.13.9 Garland, 1989, Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study, Lancet, 2, 1176, 10.1016/S0140-6736(89)91789-3 Levine, 2001, Serum 25-hydroxyvitamin D, dietary calcium in take, and distal colorectal adenoma risk, Nutr Cancer, 39, 35, 10.1207/S15327914nc391_5 Peters, 2001, Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas, Cancer Epidemiol Biomarkers Prev, 10, 1267 Platz, 2000, Plasma 1,25-dihydroxy-and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum, Cancer Epidemiology, Biomarkers Prev, 9, 1059 Tangrea, 1997, Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men, Cancer Causes Control, 8, 615, 10.1023/A:1018450531136 Wactawski-Wende, 2006, Calcium plus vitamin D supplementation and the risk of colorectal cancer, N Engl J Med, 354, 684, 10.1056/NEJMoa055222 Gorham, 2005, Vitamin D and prevention of colorectal cancer, J Steroid Biochem Mol Biol, 97, 179, 10.1016/j.jsbmb.2005.06.018 Martinez, 1996, Calcium, vitamin D, and the occurrence of colorectal cancer among women, J Natl Cancer Inst, 88, 1375, 10.1093/jnci/88.19.1375 Ding, 2008, Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: analysis of Women's Health Initiative randomized trial, Int J Cancer, 122, 1690, 10.1002/ijc.23311 Giovannucci, 2002, Epidemiologic studies of folate and colorectal neoplasia: a review, J Nutr, 132, 2350S, 10.1093/jn/132.8.2350S Sanjoaquin, 2005, Folate intake and colorectal cancer risk: a meta-analytical approach, Int J Cancer, 113, 825, 10.1002/ijc.20648 Schernhammer, 2008, Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression, Gastroenterology, 135, 770, 10.1053/j.gastro.2008.06.033 Taioli, 2009, Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review, Am J Epidemiol, 170, 1207, 10.1093/aje/kwp275 Logan, 2008, Aspirin and folic acid for the prevention of recurrent colorectal adenomas, Gastroenterology, 134, 29, 10.1053/j.gastro.2007.10.014 Wu, 2009, A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma, Am J Clin Nutr, 90, 1623, 10.3945/ajcn.2009.28319 Cole, 2007, Folic acid for the prevention of colorectal adenomas: a randomized clinical trial, JAMA, 297, 2351, 10.1001/jama.297.21.2351 Kim, 2004, Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies, Environ Mol Mutagen, 44, 10, 10.1002/em.20025 Giovannucci, 2005, DNA methylation, field effects, and colorectal cancer, J Natl Cancer Inst, 97, 1317, 10.1093/jnci/dji305 Ishihara, 2007, Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men, J Nutr, 137, 1808, 10.1093/jn/137.7.1808 Larsson, 2005, Vitamin B6 intake, alcohol consumption, and colorectal cancer: a longitudinal population-based cohort of women, Gastroenterology, 128, 1830, 10.1053/j.gastro.2005.03.005 Le Marchand, 2009, Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study, Cancer Epidemiol Biomarkers Prev, 18, 2195, 10.1158/1055-9965.EPI-09-0141 Lee, 2009, Prospective study of plasma vitamin B6 and risk of colorectal cancer in men, Cancer Epidemiol Biomarkers Prev, 18, 1197, 10.1158/1055-9965.EPI-08-1001 Theodoratou, 2008, Dietary vitamin B6 intake and the risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 17, 171, 10.1158/1055-9965.EPI-07-0621 Wei, 2005, Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women, J Natl Cancer Inst, 97, 684, 10.1093/jnci/dji116 Zhang, 2006, Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women, Am J Epidemiol, 163, 108, 10.1093/aje/kwj016 de Vogel, 2008, Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal cancer, J Nutr, 138, 2372, 10.3945/jn.108.091157 Heilbrun, 1989, Diet and colorectal cancer with special reference to fiber intake, Int J Cancer, 44, 1, 10.1002/ijc.2910440102 Potter, 1986, Diet and cancer of the colon and rectum: a case-control study, J Natl Cancer Inst, 76, 557, 10.1093/jnci/76.4.557 Stemmermann, 1990, Prospective study of alcohol intake and large bowel cancer, Digest Dis Sci, 35, 1414, 10.1007/BF01536750 Tseng, 1996, Micronutrients and the risk of colorectal adenomas, Am J Epidemiol, 144, 1005, 10.1093/oxfordjournals.aje.a008871 Wu, 1987, Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study, Br J Cancer, 55, 687, 10.1038/bjc.1987.140 van den Brandt, 1993, A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer, J Natl Cancer Inst, 85, 224, 10.1093/jnci/85.3.224 Wallace, 2003, Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study, Cancer Epidemiol Biomarkers Prev, 12, 464 Bjelakovic, 2004, Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis, Lancet, 364, 1219, 10.1016/S0140-6736(04)17138-9 Clark, 1993, Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps, Cancer Epidemiol Biomarkers Prev, 2, 41 Connelly-Frost, 2006, Selenium, apoptosis, and colorectal adenomas, Cancer Epidemiol Biomarkers Prev, 15, 486, 10.1158/1055-9965.EPI-05-0759 Jacobs, 2004, Selenium and colorectal adenoma: results of a pooled analysis, J Natl Cancer Inst, 96, 1669, 10.1093/jnci/djh310 Peters, 2006, High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program, Cancer Epidemiol Biomarkers Prev, 15, 315, 10.1158/1055-9965.EPI-05-0471 Reid, 2006, Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial, Int J Cancer, 118, 1777, 10.1002/ijc.21529 Russo, 1997, Plasma selenium levels and the risk of colorectal adenomas, Nutr Cancer, 28, 125, 10.1080/01635589709514563 Clark, 1996, Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin, JAMA, 276, 1957, 10.1001/jama.1996.03540240035027 Lippman, 2009, Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT), JAMA, 301, 39, 10.1001/jama.2008.864 1994, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers, N Engl J Med, 330, 1029, 10.1056/NEJM199404143301501 MacLennan, 1995, Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas, J Natl Cancer Inst, 87, 1760, 10.1093/jnci/87.23.1760 Greenberg, 1994, A clinical trial of antioxidant vitamins to prevent colorectal adenoma, N Engl J Med, 331, 141, 10.1056/NEJM199407213310301 Fung, 2003, Major dietary patterns and the risk of colorectal cancer in women, Arch Intern Med, 163, 309, 10.1001/archinte.163.3.309 Dixon, 2004, Dietary patterns associated with colon and rectal cancer: results from the Dietary Patterns and Cancer (DIETSCAN) Project, Am J Clin Nutr, 80, 1003, 10.1093/ajcn/80.4.1003 Slattery, 1998, Eating patterns and risk of colon cancer, Am J Epidemiol, 148, 4, 10.1093/aje/148.1.4-a Williams, 2009, Dietary patterns, food groups, and rectal cancer risk in whites and African-Americans, Cancer Epidemiol Biomarkers Prev, 18, 1552, 10.1158/1055-9965.EPI-08-1146 Giovannucci, 2004, Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies, J Nutr, 134, 2475S, 10.1093/jn/134.9.2475S Choi, 1991, Effect of cigarette smoking and alcohol consumption in the etiology of cancers of the digestive tract, Int J Cancer, 49, 381, 10.1002/ijc.2910490312 Chyou, 1996, A prospective study of colon and rectal cancer among Hawaii Japanese men, Ann Epidemiol, 6, 276, 10.1016/S1047-2797(96)00047-6 Ferraroni, 1989, Socioeconomic indicators, tobacco and alcohol in the aetiology of digestive tract neoplasms, Int J Epidemiol, 18, 556, 10.1093/ije/18.3.556 Freudenheim, 1990, Lifetime alcohol intake and risk of rectal cancer in western New York, Nutr Cancer, 13, 101, 10.1080/01635589009514050 Hermann, 2009, Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg, Cancer Causes Control, 10.1007/s10552-009-9366-3 Hirayama, 1989, Association between alcohol consumption and cancer of the sigmoid colon: observations from a Japanese cohort study, Lancet, 2, 725, 10.1016/S0140-6736(89)90782-4 Hu, 1991, Diet and cancer of the colon and rectum: a case-control study in China, Int J Epidemiol, 20, 362, 10.1093/ije/20.2.362 Kabat, 1986, Beer consumption and rectal cancer, Int J Epidemiol, 15, 494, 10.1093/ije/15.4.494 Klatsky, 1988, The relations of alcoholic beverage use to colon and rectal cancer, Am J Epidemiol, 128, 1007, 10.1093/oxfordjournals.aje.a115045 Kune, 1987, Case-control study of alcoholic beverages as etiological factors: the Melbourne colorectal cancer study, Nutr Cancer, 9, 43, 10.1080/01635588709513909 Longnecker, 1990, A case-control study of alcoholic beverage consumption in relation to risk of cancer of the right colon and rectum in men, Cancer Causes Control, 1, 5, 10.1007/BF00053178 Meyer, 1993, Alcohol and nutrients in relation to colon cancer in middle-aged adults, Am J Epidemiol, 138, 225, 10.1093/oxfordjournals.aje.a116851 Miller, 1983, Food items and food groups as risk factors in a case-control study of diet and colo-rectal cancer, Int J Cancer, 32, 155, 10.1002/ijc.2910320204 Murata, 1999, Genotype difference of aldehyde dehydrogenase 2 gene in alcohol drinkers influences the incidence of Japanese colorectal cancer patients, Jpn J Cancer Res, 90, 711, 10.1111/j.1349-7006.1999.tb00805.x Newcomb, 1993, Cancer of the large bowel in women in relation to alcohol consumption: a case-control study in Wisconsin (United States), Cancer Causes Control, 4, 405, 10.1007/BF00050858 Peters, 1989, A case-control study of occupational and dietary factors in colorectal cancer in young men by subsite, Cancer Res, 49, 5459 Peters, 1992, Diet and colon cancer in Los Angeles County, California, Cancer Causes Control, 3, 457, 10.1007/BF00051359 Pickle, 1984, Colorectal cancer in rural Nebraska, Cancer Res, 44, 363 Pollack, 1984, Prospective study of alcohol consumption and cancer, N Engl J Med, 310, 617, 10.1056/NEJM198403083101003 Tuyns, 1982, Cancers of the digestive tract, alcohol and tobacco, Int J Cancer, 30, 9, 10.1002/ijc.2910300103 Williams, 1977, Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey, J Natl Cancer Inst, 58, 525, 10.1093/jnci/58.3.525 Bidoli, 1992, Food consumption and cancer of the colon and rectum in north-eastern Italy, Int J Cancer, 50, 223, 10.1002/ijc.2910500211 Le Marchand, 1997, Associations of sedentary lifestyle, obesity, smoking, alcohol use and diabetes with the risk of colorectal cancer, Cancer Research, 57, 4787 Slattery, 1997, Are dietary factors involved in DNA methylation associated with colon cancer?, Nutr Cancer, 28, 52, 10.1080/01635589709514553 Slattery, 1990, Tobacco, alcohol, coffee, and caffeine as risk factors for colon cancer in a low-risk population, Epidemiology, 1, 141, 10.1097/00001648-199003000-00010 Giovannucci, 1995, Alcohol, low-methionine—low-folate diets, and risk of colon cancer in men, J Natl Cancer Inst, 87, 265, 10.1093/jnci/87.4.265 Giovannucci, 1993, Folate, methionine, and alcohol intake and risk of colorectal adenoma, J Natl Cancer Inst, 85, 875, 10.1093/jnci/85.11.875 Cho, 2004, Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies, Ann Intern Med, 140, 603, 10.7326/0003-4819-140-8-200404200-00007 Ferrari, 2007, Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC), Int J Cancer, 121, 2065, 10.1002/ijc.22966 Bagnardi, 2001, A meta-analysis of alcohol drinking and cancer risk, Br J Cancer, 85, 1700, 10.1054/bjoc.2001.2140 Poynter, 2009, Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status, Cancer Epidemiol Biomarkers Prev, 18, 2745, 10.1158/1055-9965.EPI-09-0517 Seitz, 1990, Possible role of acetaldehyde in ethanol-related rectal cocarcinogenesis in the rat, Gastroenterology, 98, 406, 10.1016/0016-5085(90)90832-L Choi, 1999, Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon, J Nutr, 129, 1945, 10.1093/jn/129.11.1945 Kune, 1992, Alcohol consumption and the etiology of colorectal cancer: a review of the scientific evidence from 1957 to 1991, Nutr Cancer, 18, 97, 10.1080/01635589209514210 Doll, 1976, Mortality in relation to smoking: 20 years' observations on male British doctors, Br Med J, 2, 1525, 10.1136/bmj.2.6051.1525 Hammond, 1958, Smoking and death rates: report on forty-four months of followup of 187,783 men. II. Death rates by cause, JAMA, 166, 1294, 10.1001/jama.1958.02990110030007 Kahn, 1966, The Dorn study of smoking and mortality among US Veterans: report on eight and one-half years of observation, Natl Cancer Inst Monogr, 19, 1 Rogot, 1980, Smoking and causes of death among US veterans: 16 years of observation, Public Health Rep, 95, 213 Giovannucci, 1994, A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women, J Natl Cancer Inst, 86, 192, 10.1093/jnci/86.3.192 Giovannucci, 1994, A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US men, J Natl Cancer Inst, 86, 183, 10.1093/jnci/86.3.183 1986, Tobacco smoking, IARC Monogr Eval Carcinog Risks Hum, 38, 397 Yamasaki, 1977, Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine, Proceedings of the National Acad Sci U S A, 74, 3555, 10.1073/pnas.74.8.3555 Giovannucci, 2001, An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 10, 725 Botteri, 2008, Cigarette smoking and adenomatous polyps: a meta-analysis, Gastroenterology, 134, 388, 10.1053/j.gastro.2007.11.007 Botteri, 2008, Smoking and colorectal cancer: a meta-analysis, JAMA, 300, 2765, 10.1001/jama.2008.839 Liang, 2009, Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis, Int J Cancer, 124, 2406, 10.1002/ijc.24191 Tsoi, 2009, Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies, Clin Gastroenterol Hepatol, 7, 682, 10.1016/j.cgh.2009.02.016 Hannan, 2009, The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States, Cancer Epidemiol Biomarkers Prev, 18, 3362, 10.1158/1055-9965.EPI-09-0661 Limburg, 2003, Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of post-menopausal women, Clin Gastroenterol and Hepatol, 1, 202, 10.1016/S1542-3565(03)70037-8 Chao, 2000, Cigarette smoking and colorectal cancer mortality in the cancer prevention study II, J Natl Cancer Inst, 92, 1888, 10.1093/jnci/92.23.1888 Heineman, 1994, Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of US veterans and a review, Int J Cancer, 59, 728, 10.1002/ijc.2910590603 Newcomb, 1995, Cigarette smoking in relation to risk of large bowel cancer in women, Cancer Res, 55, 4906 Abrams, 2008, Cigarette smoking and the colorectal adenoma-carcinoma sequence, Gastroenterology, 134, 617, 10.1053/j.gastro.2007.12.015 Lee, 1991, Physical activity and risk of developing colorectal cancer among college alumni, J Natl Cancer Inst, 83, 1324, 10.1093/jnci/83.18.1324 Giovannucci, 1995, Physical activity, obesity, and risk for colon cancer and adenoma in men, Ann Intern Med, 122, 327, 10.7326/0003-4819-122-5-199503010-00002 Martinez, 1997, Leisure-time physical activity, body size, and colon cancer in women, J Natl Cancer Inst, 89, 948, 10.1093/jnci/89.13.948 Pischon, 2006, Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC), J Natl Cancer Inst, 98, 920, 10.1093/jnci/djj246 Giovannucci, 1996, Physical activity, obesity, and risk of colorectal adenoma in women (United States), Cancer Causes Control, 7, 253, 10.1007/BF00051301 Ning, 2009, A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies, Obes Rev Larsson, 2007, Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies, Am J Clin Nutr, 86, 556, 10.1093/ajcn/86.3.556 Giovannucci, 1995, Insulin and colon cancer, Cancer Causes Control, 6, 164, 10.1007/BF00052777 Ma, 2004, A prospective study of plasma C-peptide and colorectal cancer risk in men, J Natl Cancer Inst, 96, 546, 10.1093/jnci/djh082 Saydah, 2003, Association of markers of insulin and glucose control with subsequent colorectal cancer risk, Cancer Epidemiol Biomarkers Prev, 12, 412 Jenab, 2007, Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition, Int J Cancer, 121, 368, 10.1002/ijc.22697 Kaaks, 2000, Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women, J Natl Cancer Inst, 92, 1592, 10.1093/jnci/92.19.1592 Otani, 2007, Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study, Int J Cancer, 120, 2007, 10.1002/ijc.22556 Stocks, 2008, Components of the metabolic syndrome and colorectal cancer risk; a prospective study, Int J Obes (Lond), 32, 304, 10.1038/sj.ijo.0803713 Wei, 2005, A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women, Cancer Epidemiol Biomarkers Prev, 14, 850, 10.1158/1055-9965.EPI-04-0661 Wei, 2005, Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study, J Natl Cancer Inst, 97, 1688, 10.1093/jnci/dji376 Otake, 2005, Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance, Clin Cancer Res, 11, 3642, 10.1158/1078-0432.CCR-04-1868 Hu, 1999, Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women, J Natl Cancer Inst, 91, 542, 10.1093/jnci/91.6.542 Larsson, 2005, Diabetes and colorectal cancer incidence in the cohort of Swedish men, Diabetes Care, 28, 1805, 10.2337/diacare.28.7.1805 La Vecchia, 1997, Diabetes mellitus and colorectal cancer risk, Cancer Epidemiol Biomarkers Prev, 6, 1007 Limburg, 2005, Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study, Cancer Epidemiol Biomarkers Prev, 14, 133, 10.1158/1055-9965.133.14.1 Limburg, 2006, Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study, Am J Gastroenterol, 101, 1872, 10.1111/j.1572-0241.2006.00725.x Rinaldi, 2008, Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition, Cancer Epidemiol Biomarkers Prev, 17, 3108, 10.1158/1055-9965.EPI-08-0495 Khaw, 2004, Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer–Norfolk study, Cancer Epidemiol Biomarkers Prev, 13, 915, 10.1158/1055-9965.915.13.6 Lin, 2005, Hemoglobin A1c concentrations and risk of colorectal cancer in women, Cancer Epidemiol Biomarkers Prev, 14, 3010, 10.1158/1055-9965.EPI-05-0533 Platz, 1999, Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States), Cancer Causes Control, 10, 379, 10.1023/A:1008953611657 Wei, 2006, C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women, Cancer Epidemiol Biomarkers Prev, 15, 750, 10.1158/1055-9965.EPI-05-0820 Shoelson, 2007, Obesity, inflammation, and insulin resistance, Gastroenterology, 132, 2169, 10.1053/j.gastro.2007.03.059 Kim, 2008, Circulating levels of inflammatory cytokines and risk of colorectal adenomas, Cancer Res, 68, 323, 10.1158/0008-5472.CAN-07-2924 Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 Slattery, 2004, Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway, Cancer Epidemiol Biomarkers Prev, 13, 538, 10.1158/1055-9965.538.13.4 Delage, 2007, The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers, Nutr J, 6, 20, 10.1186/1475-2891-6-20 Kim, 2006, Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States), Cancer Causes Control, 17, 1299, 10.1007/s10552-006-0075-x Colbert, 2001, Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers, Cancer Epidemiol Biomarkers Prev, 10, 265 Colditz, 1997, Physical activity and reduced risk of colon cancer: implications for prevention, Cancer Causes Control, 8, 649, 10.1023/A:1018458700185 Kono, 1991, Physical activity, dietary habits and adenomatous polyps of the sigmoid colon: a study of self-defense officials in Japan, J Clin Epidemiol, 44, 1255, 10.1016/0895-4356(91)90158-6 Neugut, 1996, Leisure and occupational physical activity and risk of colorectal adenomatous polyps, Int J Cancer, 68, 744, 10.1002/(SICI)1097-0215(19961211)68:6<744::AID-IJC9>3.0.CO;2-3 Thun, 1992, Risk factors for fatal colon cancer in a large prospective study, J Natl Cancer Inst, 84, 1491, 10.1093/jnci/84.19.1491 Martinez, 1996, Physical activity, body size, and colorectal cancer in women, Am J Epidemiol, 143, S73 Slattery, 1997, Energy balance and colon cancer—beyond physical activity, Cancer Res, 57, 75 Wolin, 2009, Physical activity and colon cancer prevention: a meta-analysis, Br J Cancer, 100, 611, 10.1038/sj.bjc.6604917 Dowse, 1991, Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians, Diabetes Care, 14, 271, 10.2337/diacare.14.4.271 Regensteiner, 1991, Relationship between habitual physical activity and insulin levels among nondiabetic men and women, Diabetes Care, 14, 1066, 10.2337/diacare.14.11.1066 Breuer-Katschinski, 2000, Long-term use of nonsteroidal antiinflammatory drugs and the risk of colorectal adenomas, Digestion, 61, 129, 10.1159/000007745 Coogan, 2000, NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease, Cancer Causes Control, 11, 249, 10.1023/A:1008931708716 Friedman, 1998, Drugs and colon cancer, Pharmacoepidemiol Drug Saf, 7, 99, 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0 Friis, 2009, Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study, Cancer Causes Control, 20, 731, 10.1007/s10552-008-9286-7 Friis, 2003, A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin, Br J Cancer, 88, 684, 10.1038/sj.bjc.6600760 Garcia Rodriguez, 2000, Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study, Epidemiology, 11, 376, 10.1097/00001648-200007000-00003 Garcia-Rodriguez, 2001, Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs, Epidemiology, 12, 471, 10.1097/00001648-200101000-00015 Grau, 2009, Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study, J Natl Cancer Inst, 101, 267, 10.1093/jnci/djn484 Jacobs, 2007, A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence, J Natl Cancer Inst, 99, 608, 10.1093/jnci/djk132 Juarranz, 2002, Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer, Eur J Cancer Prev, 11, 465, 10.1097/00008469-200210000-00009 Kahn, 1998, Risk factors for self-reported colon polyps, J Gen Intern Med, 13, 303, 10.1046/j.1525-1497.1998.00095.x La Vecchia, 1997, Aspirin and colorectal cancer, Br J Cancer, 76, 675, 10.1038/bjc.1997.444 Morimoto, 2002, Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?, Cancer Epidemiol Biomarkers Prev, 11, 1012 Sandler, 1998, Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas, Gastroenterology, 114, 441, 10.1016/S0016-5085(98)70526-8 Sorensen, 2003, Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study, Br J Cancer, 88, 1687, 10.1038/sj.bjc.6600945 Tangrea, 2003, Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States), Cancer Causes Control, 14, 403, 10.1023/A:1024990617158 Cruz-Correa, 2002, Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study, Gastroenterology, 122, 641, 10.1053/gast.2002.31890 Giardiello, 1993, Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis, N Engl J Med, 328, 1313, 10.1056/NEJM199305063281805 Hallak, 2003, Rofecoxib reduces polyp recurrence in familial polyposis, Dig Dis Sci, 48, 1998, 10.1023/A:1026130623186 Labayle, 1991, Sulindac causes regression of rectal polyps in familial adenomatous polyposis, Gastroenterology, 101, 635, 10.1016/0016-5085(91)90519-Q Rigau, 1991, Effects of long-term sulindac therapy on colonic polyposis, Ann Intern Med, 115, 952, 10.7326/0003-4819-115-12-952 Steinbach, 2000, The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis, N Engl J Med, 342, 1946, 10.1056/NEJM200006293422603 Waddell, 1989, Sulindac for polyposis of the colon, Am J Surg, 157, 175, 10.1016/0002-9610(89)90442-X Waddell, 1983, Sulindac for polyposis of the colon, J Surg Oncol, 24, 83, 10.1002/jso.2930240119 Baron, 2003, A randomized trial of aspirin to prevent colorectal adenomas, N Engl J Med, 348, 891, 10.1056/NEJMoa021735 Benamouzig, 2003, Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial, Gastroenterology, 125, 328, 10.1016/S0016-5085(03)00887-4 Sandler, 2003, A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer, N Engl J Med, 348, 883, 10.1056/NEJMoa021633 Cole, 2009, Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials, J Natl Cancer Inst, 101, 256, 10.1093/jnci/djn485 Cook, 2005, Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial, JAMA, 294, 47, 10.1001/jama.294.1.47 Gann, 1993, Low-dose aspirin and incidence of colorectal tumors in a randomized trial, J Natl Cancer Inst, 85, 1220, 10.1093/jnci/85.15.1220 Chan, 2008, Aspirin dose and duration of use and risk of colorectal cancer in men, Gastroenterology, 134, 21, 10.1053/j.gastro.2007.09.035 Chan, 2005, Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer, JAMA, 294, 914, 10.1001/jama.294.8.914 Flossmann, 2007, Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies, Lancet, 369, 1603, 10.1016/S0140-6736(07)60747-8 Chan, 2004, A prospective study of aspirin use and the risk of colorectal adenoma, Ann Intern Med, 140, 157, 10.7326/0003-4819-140-3-200402030-00006 Chan, 2005, Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma, J Natl Cancer Inst, 97, 457, 10.1093/jnci/dji066 Bigler, 2001, CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk, Cancer Res, 61, 3566 Arber, 2006, Celecoxib for the prevention of colorectal adenomatous polyps, N Engl J Med, 355, 885, 10.1056/NEJMoa061652 Baron, 2006, A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas, Gastroenterology, 131, 1674, 10.1053/j.gastro.2006.08.079 Bertagnolli, 2006, Celecoxib for the prevention of sporadic colorectal adenomas, N Engl J Med, 355, 873, 10.1056/NEJMoa061355 Baron, 2008, Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial, Lancet, 372, 1756, 10.1016/S0140-6736(08)61490-7 Bresalier, 2005, Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial, N Engl J Med, 352, 1092, 10.1056/NEJMoa050493 Solomon, 2005, Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention, N Engl J Med, 352, 1071, 10.1056/NEJMoa050405 Solomon, 2006, Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas, Circulation, 114, 1028, 10.1161/CIRCULATIONAHA.106.636746 Solomon, 2008, Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis, Circulation, 117, 2104, 10.1161/CIRCULATIONAHA.108.764530 Bertagnolli, 2009, Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial, Cancer Prev Res (Phila Pa), 2, 310, 10.1158/1940-6207.CAPR-08-0206 Chan, 2007, Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease, JAMA, 298, 1412, 10.1001/jama.298.12.1412 Boyapati, 2003, Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use?, Cancer Epidemiol Biomarkers Prev, 12, 631 Collet, 1999, Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing, Br J Cancer, 81, 62, 10.1038/sj.bjc.6690651 Hauret, 2004, Physical activity and reduced risk of incident sporadic colorectal adenomas: observational support for mechanisms involving energy balance and inflammation modulation, Am J Epidemiol, 159, 983, 10.1093/aje/kwh130 Kim, 2008, Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans, Am J Epidemiol, 168, 1292, 10.1093/aje/kwn255 Kune, 1988, Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study, Cancer Res, 48, 4399 Lieberman, 2003, Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals, JAMA, 290, 2959, 10.1001/jama.290.22.2959 Lipworth, 2004, A population-based cohort study of mortality among users of ibuprofen in Denmark, Am J Ther, 11, 156, 10.1097/00045391-200405000-00002 Logan, 1993, Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme, BMJ, 307, 285, 10.1136/bmj.307.6899.285 Martin, 2002, Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas, Gastroenterology, 123, 1770, 10.1053/gast.2002.37053 Martinez, 1995, Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals, Cancer Epidemiol Biomarkers Prev, 4, 703 Muscat, 1994, Nonsteroidal antiinflammatory drugs and colorectal cancer, Cancer, 74, 1847, 10.1002/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-# Peleg, 1996, Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia, Dig Dis Sci, 41, 1319, 10.1007/BF02088554 Reeves, 1996, Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women, Cancer Epidemiol Biomarkers Prev, 5, 955 Sansbury, 2005, Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and whites, Am J Epidemiol, 162, 548, 10.1093/aje/kwi248 Sansbury, 2006, COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States), Cancer Causes Control, 17, 257, 10.1007/s10552-005-0417-0 Shadman, 2009, Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk, World J Gastroenterol, 15, 2336, 10.3748/wjg.15.2336 Smalley, 1999, Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study, Arch Intern Med, 159, 161, 10.1001/archinte.159.2.161 Meyskens, 1998, Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention, J Natl Cancer Inst, 90, 1212, 10.1093/jnci/90.16.1212 McLaren, 2008, Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas, Cancer Prev Res (Phila Pa), 1, 514, 10.1158/1940-6207.CAPR-08-0074 Zell, 2009, Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas, Cancer Prev Res (Phila Pa), 2, 209, 10.1158/1940-6207.CAPR-08-0203 Oshima, 1996, Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2), Cell, 87, 803, 10.1016/S0092-8674(00)81988-1 Williams, 2000, Host cyclooxygenase-2 modulates carcinoma growth, J Clin Invest, 105, 1589, 10.1172/JCI9621 Dubois, 2000, Review article: cyclooxygenase—a target for colon cancer prevention, Aliment Pharmacol Ther, 14, 64, 10.1046/j.1365-2036.2000.014s1064.x Eberhart, 1994, Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183, 10.1016/0016-5085(94)90246-1 Chen, 2004, Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients, Cancer Res, 64, 3694, 10.1158/0008-5472.CAN-03-3264 Chan, 2007, Aspirin and the risk of colorectal cancer in relation to the expression of COX-2, N Engl J Med, 356, 2131, 10.1056/NEJMoa067208 Barry, 2009, Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence—data from a randomized clinical trial, Cancer Epidemiol Biomarkers Prev, 18, 2726, 10.1158/1055-9965.EPI-09-0363 Kopp, 1994, Inhibition of NF-kappa B by sodium salicylate and aspirin, Science, 265, 956, 10.1126/science.8052854 Schwenger, 1997, Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation, Proc Natl Acad Sci U S A, 94, 2869, 10.1073/pnas.94.7.2869 Martinez, 2003, Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene, Proc Natl Acad Sci U S A, 100, 7859, 10.1073/pnas.1332465100 2007, Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: US Preventive Services Task Force recommendation statement, Ann Intern Med, 146, 361, 10.7326/0003-4819-146-5-200703060-00008 Rostom, 2007, Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the US Preventive Services Task Force, Ann Intern Med, 146, 376, 10.7326/0003-4819-146-5-200703060-00010 Bardia, 2007, Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality, J Natl Cancer Inst, 99, 881, 10.1093/jnci/djk200 Chan, 2006, Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events, Circulation, 113, 1578, 10.1161/CIRCULATIONAHA.105.595793 Limburg, 2007, Aspirin chemoprevention for colorectal cancer: helpful, harmful, or still too soon to tell?, Gastroenterology, 133, 717, 10.1053/j.gastro.2007.06.040 Dube, 2007, The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the US Preventive Services Task Force, Ann Intern Med, 146, 365, 10.7326/0003-4819-146-5-200703060-00009 Cuzick, 2009, Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement, Lancet Oncol, 10, 501, 10.1016/S1470-2045(09)70035-X Chan, 2009, Aspirin use and survival after diagnosis of colorectal cancer, JAMA, 302, 649, 10.1001/jama.2009.1112 Zell, 2009, Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis, Cancer, 115, 5662, 10.1002/cncr.24705 Dornschneider, 1990, The effects of sex steroids on colon carcinogenesis, Anticancer Drugs, 1, 15, 10.1097/00001813-199010000-00003 McMichael, 1985, Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer, J Natl Cancer Inst, 75, 185 Lampe, 1993, Sex differences in colonic function: a randomised trial, Gut, 34, 531, 10.1136/gut.34.4.531 Campagnoli, 1993, Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels, Gynecol Endocrinol, 7, 251, 10.3109/09513599309152509 Issa, 1994, Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon, Nat Genet, 7, 536, 10.1038/ng0894-536 Risch, 1995, Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study, Cancer Epidemiol Biomarkers Prev, 4, 21 Troisi, 1997, A prospective study of menopausal hormones and risk of colorectal cancer (United States), Cancer Causes Control, 8, 130, 10.1023/A:1018455810238 Weiss, 1981, Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors, J Natl Cancer Inst, 67, 57 Calle, 1995, Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women, J Natl Cancer Inst, 87, 517, 10.1093/jnci/87.7.517 Corrao, 2008, Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation, Ann Oncol, 19, 150, 10.1093/annonc/mdm404 Fernandez, 1998, Hormone replacement therapy and risk of colon and rectal cancer, Cancer Epidemiol Biomarkers Prev, 7, 329 Folsom, 1995, Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women, Am J Public Health, 85, 1128, 10.2105/AJPH.85.8_Pt_1.1128 Furner, 1989, A case-control study of large bowel cancer and hormone exposure in women, Cancer Res, 49, 4936 Hammond, 1979, Effects of long-term estrogen replacement therapy, Am J Obstet Gynecol, 133, 537, 10.1016/0002-9378(79)90289-8 Jacobs, 1994, Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA), Cancer Causes Control, 5, 359, 10.1007/BF01804987 Johnson, 2009, Menopausal hormone therapy and risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 18, 196, 10.1158/1055-9965.EPI-08-0596 Kampman, 1997, Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States, Cancer Causes Control, 8, 146, 10.1023/A:1018459911147 Nachtigall, 1979, Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems, Obstet Gynecol, 54, 74, 10.1097/00006250-197907000-00017 Paganini-Hill, 1999, Estrogen replacement therapy and colorectal cancer risk in elderly women, Dis Colon Rectum, 42, 1300, 10.1007/BF02234219 Persson, 1996, Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy—long-term follow-up of a Swedish cohort, Int J Cancer, 67, 327, 10.1002/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T Peters, 1990, Reproductive factors and colon cancers, Br J Cancer, 61, 741, 10.1038/bjc.1990.166 Potter, 1983, Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study, J Natl Cancer Inst, 71, 703 Prihartono, 2000, A case-control study of use of postmenopausal female hormone supplements in relation to the risk of large bowel cancer, Cancer Epidemiol Biomarkers Prev, 9, 443 Rennert, 2009, Use of hormone replacement therapy and the risk of colorectal cancer, J Clin Oncol, 27, 4542, 10.1200/JCO.2009.22.0764 Slattery, 2001, Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer, Cancer Res, 61, 126 Jacobson, 1995, Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States), Cancer Causes Control, 6, 513, 10.1007/BF00054159 Peipins, 1997, Reproductive history, use of exogenous hormones, and risk of colorectal adenomas, Cancer Epidemiol Biomarkers Prev, 6, 671 Potter, 1996, Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study, Cancer Epidemiol Biomarkers Prev, 5, 779 Wolf, 2007, Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?, Cancer Epidemiol Biomarkers Prev, 16, 676, 10.1158/1055-9965.EPI-06-0883 Woodson, 2001, Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial, J Natl Cancer Inst, 93, 1799, 10.1093/jnci/93.23.1799 Grodstein, 1998, Postmenopausal hormone use and risk for colorectal cancer and adenoma, Ann Intern Med, 128, 705, 10.7326/0003-4819-128-9-199805010-00001 Grodstein, 1999, Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis, Am J Med, 106, 574, 10.1016/S0002-9343(99)00063-7 Hebert-Croteau, 1998, A meta-analysis of hormone replacement therapy and colon cancer in women, Cancer Epidemiol Biomarkers Prev, 7, 653 Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Ritenbaugh, 2008, Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial, Cancer Epidemiol Biomarkers Prev, 17, 2609, 10.1158/1055-9965.EPI-08-0385 Newcomb, 2007, Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women, Cancer Res, 67, 7534, 10.1158/0008-5472.CAN-06-4275 Tannen, 2007, Estrogen affects post-menopausal women differently than estrogen plus progestin replacement therapy, Hum Reprod, 22, 1769, 10.1093/humrep/dem031 Hildebrand, 2009, Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in Cancer Prevention Study II, Cancer Epidemiol Biomarkers Prev, 18, 2835, 10.1158/1055-9965.EPI-09-0596 Prentice, 2009, Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study, Cancer Epidemiol Biomarkers Prev, 18, 1531, 10.1158/1055-9965.EPI-08-1209 Platz, 2000, Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men, Cancer Causes Control, 11, 579, 10.1023/A:1008999232442 Parkin, 2009, The potential for prevention of colorectal cancer in the UK, Eur J Cancer Prev, 18, 179, 10.1097/CEJ.0b013e32830c8d83 Wei, 2009, Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study, Am J Epidemiol, 170, 863, 10.1093/aje/kwp210 Pai, 2002, Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy, Nat Med, 8, 289, 10.1038/nm0302-289 He, 1999, PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs, Cell, 99, 335, 10.1016/S0092-8674(00)81664-5 Lehmann, 1997, Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs, J Biol Chem, 272, 3406, 10.1074/jbc.272.6.3406 Hsu, 2000, The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2, J Biol Chem, 275, 11397, 10.1074/jbc.275.15.11397 Myung, 2006, 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis, Proc Natl Acad Sci U S A, 103, 12098, 10.1073/pnas.0603235103 Yan, 2009, 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors, Proc Natl Acad Sci U S A, 106, 9409, 10.1073/pnas.0902367106 Yan, 2004, 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers, Proc Natl Acad Sci U S A, 101, 17468, 10.1073/pnas.0406142101 Cai, 2006, Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk, J Clin Oncol, 24, 5010, 10.1200/JCO.2006.06.4931 Chen, 1999, MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among US men and women: an example of gene-environment interactions in colorectal tumorigenesis, J Nutr, 129, 560S, 10.1093/jn/129.2.560S